Skip to content
MedsAcross

Medicine

Erythromycin 2% gel

Erythromycin · Topical
Available on requestPrescription onlyUS FDAGeneric name

Erythromycin 2% gel is a generic prescription medicine for topical use, made by 2 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20-25°C (68-77°F). Store and dispense in original container.

Key facts

Active ingredient (INN)
Erythromycin
Brand
Sold under the generic name
Strength
2%
Dosage form
Gel
Route
Topical
Packs
1 tube and 3 more
Manufacturers
Bryant Ranch PrepackPadagis Israel Pharmaceuticals
Origin register
US FDA, United States
Storage
Store at 20-25°C (68-77°F). Store and dispense in original container.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
D10AF02 Erythromycin
HS code (indicative)
3004.20Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
12 June 2008
Identifiers
RxCUI 310152DailyMed set ID b7d11564-c92d-4eed-bdd9-8fc355e7dfc7, 939bccc7-b4a0-4a5c-a6f5-b12627ff8e9b, dd64459e-c88f-4ca8-b63b-fb96377a3921 +1NDC 72162-1444, 63629-8653, 45802-966 +1Application ANDA063211

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
1 tube in 1 carton / 30 g in 1 tube45802-966-94Padagis Israel Pharmaceuticals8 September 2008
1 tube in 1 carton / 60 g in 1 tube45802-966-96Padagis Israel Pharmaceuticals12 June 2008
1 tube in 1 carton / 30 g in 1 tube63629-8652-1Bryant Ranch Prepack8 September 2008
1 tube in 1 carton / 60 g in 1 tube63629-8653-1Bryant Ranch Prepack12 June 2008
1 tube in 1 carton / 30 g in 1 tube72162-1444-3Bryant Ranch Prepack16 August 2023
1 tube in 1 carton / 60 g in 1 tube72162-1444-6Bryant Ranch Prepack16 August 2023

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 25 June 1964Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Erythromycin

Clinical summary

Erythromycin is a macrolide antimicrobial indicated in the treatment of infections caused by susceptible strains of the designated organisms in the diseases listed below, among other approved uses. MedsAcross supplies Erythromycin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Erythromycin

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Erythromycin 2% gel for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.